These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis.
    Author: Rosenberg DW, Liu Y.
    Journal: Cancer Lett; 1995 Jun 08; 92(2):209-14. PubMed ID: 7600532.
    Abstract:
    Repetitive treatment with the organotropic colon carcinogen, 1,2-dimethylhydrazine (DMH), produces tumors in susceptible mouse strains that exhibit pathological features associated with the human disease. As in human populations, the genetic background of laboratory animals comprises a significant component to this organ-specific carcinogenesis, and several mouse lines, including AKR/J and DBA/2J are highly resistant to the tumorigenic effects of DMH. During the course of ongoing studies to establish phenotypic differences between susceptible (SWR/J and P/J) and resistant strains, we have examined the colonic mucosa of DMH-treated mice for the presence of aberrant crypt foci (ACF). ACF represent an early morphological lesion in stepwise progression of colon cancer. In Experiment 1, 6-week-old SWR/J and AKR/J mice were injected with DMH (35 and 20 mg/kg, respectively) once a week for 2 weeks. Five weeks later, colons were removed and ACF visualized at low magnification by light microscopy after methylene blue-staining. Only SWR/J mice revealed focal atypia indicative of preneoplastic change. To obtain additional information about their morphology, tissue sections containing ACF were sectioned and stained with H&E. ACF are larger and have a thicker epithelial lining than normal crypts. H&E confirmed the absence of these lesions in untreated SWR/J and DMH-exposed AKR/J mice. In Experiment 2, SWR/J and DBA/2J mice were injected with DMH (35 mg/kg) once a week for 2 weeks. Nine weeks later, colons were analyzed for ACF formation. Comparable to the first experiment, no ACF were observed in the colonic mucosa of the resistant DBA/2J line. In contrast, ACF were readily identified in the middle and distal colons of similarly exposed SWR/J mice. This differential response between resistant and susceptible mouse lines further supports an important role for ACF in the stepwise progression of colon cancer.
    [Abstract] [Full Text] [Related] [New Search]